12
Views
3
CrossRef citations to date
0
Altmetric
Original Papers

Intraoperative High-Dose-Rate Brachytherapy (IBT) for Locally Unresectable Intraabdominal Malignancy

, , , , , , & show all
Pages 523-528 | Published online: 11 Mar 2016

References

  • Wanebo H. J., Gaker D. L., Whitehill R., Morgan R. F., Constable W. C. Pelvic recurrence of rectal cancer. Ann Surg, 1986, 205: 482–95.
  • Nuyttens J. J., Kolkman-Deurloo I. K., Vermaas M., Ferenschild F. T., Graveland W. J., De Wilt J. et al. High-dose-rate intraoperative radiotherapy for close or positive margins in patients with locally advanced or recurrent rectal cancer. Int J Radiat Oncol Biol Phys, 2004, 58: 106–12.
  • Ferenschild F. T., Vermaas M., Nuyttens J. J., Graveland W. J., Marinelli A. W., van der Sijp J. R. et al. Value of intraoperative radiotherapy in locally advanced rectal cancer. Dis Colon Rectum, 2006, 49: 1257–65.
  • Nag S., Martinez-Monge R., Mills J., Bauer C., Grecula J., Nieroda C. et al. Intraoperative high dose rate brachytherapy in recurrent or metastatic colorectal carcinoma. Ann Surg Oncol, 1998, 5: 16–22.
  • Alektiar K. M., Zelefsky M. J., Paty P. B., Guillem J., Saltz L. B., Cohen A. M. et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys, 2000, 48: 219–26.
  • Harrison L. B., Minsky B. D., Enker W. E., Mychalczak B., Guillem J., Paty P. B. et al. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys, 1998, 42: 325–30.
  • van den Brink M., Stiggelbout A. M., van den Hout W. B., Kievit J., Kranenbarg E. K., Marijnen C. A. M. et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol, 2004, 22: 3958–3964.
  • Suzuki K., Gunderson L. L., Devine R. M., Weaver A. L., Dozois R. R., Ilstrup D. M. et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer, 1995, 75: 939–52.
  • Minsky B. D., Cohen A. M., Fass D., Enker W. E., Sigurdson E., Harrison L. Intraoperative brachytherapy alone for incomplete resected recurrent rectal cancer. Radiother Oncol, 1991, 21: 115–20.
  • Goes R. N., Beart R. W., Simons A. J., Gunderson L. L., Grado G., Streeter O. Use of brachytherapy in management of locally recurrent rectal cancer. Dis Colon Rectum, 1997, 40: 1177–9.
  • Wallace H. J., Willett C. G., Shellito P. C. et al. Intraoperative radiation therapy for locally advanced recurrent rectal or recto-sigmoid cancer. J Surg Oncol, 1995, 60: 122–7.
  • Valentini V., Morganti A. G., De Franco A., Coco C., Ratto C., Battista Doglietto G. et al. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome. Cancer, 1999, 86: 2612–24.
  • Martinez-Monge R., Nag S., Martin E. W. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma. Cancer, 1999, 86: 236–47.
  • Mannaerts G. H., Rutten H. J., Martijn H., Hanssens P. E., Wiggers T. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum, 2001, 44: 1749–58.
  • Shaw E., Gunderson L. L., Martin J., Beart R. W., Nagorney D. M., Podratz K. C. Peripheral and ureteral tolerance of intraoperative radiation therapy: clinical and dose response analysis. Radiat Oncol, 1990, 18: 247–55.
  • Nag S., Tippin D., Ruymann F. B. Intraoperative high-dose-rate brachytherapy for the treatment of pediatric tumors: the Ohio State University experience. Int J Radiat Oncol Biol Phys, 2001, 51: 729–35.
  • Goodman K. A., Wolden S. L., LaQuaqlia M. P., Alektiar K., D’Souza D., Zelefsky M. J. Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experience. Brachytherapy, 2003, 2: 139–46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.